Drug name - Xipere

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8636713 BAUSCH AND LOMB INC Methods and devices for drug delivery to ocular tissue using microneedle May, 2027

(4 years from now)

US9636332 BAUSCH AND LOMB INC Methods and devices for the treatment of ocular diseases in human subjects Nov, 2033

(11 years from now)

US9937075 BAUSCH AND LOMB INC Apparatus and methods for ocular injection May, 2034

(11 years from now)

Drugs and Companies using TRIAMCINOLONE ACETONIDE ingredient

Treatment: Treatment of macular edema associated with uveitis

Dosage: SUSPENSION;INJECTION

More Information on Dosage
Strength Dosage Availability
40MG/ML SUSPENSION;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.